RDNT's Aroon Indicator triggered a bullish signal on November 11, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 210 similar instances where the Aroon Indicator showed a similar pattern. In 181 of the 210 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 86%.
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on RDNT as a result. In 64 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
The Moving Average Convergence Divergence (MACD) for RDNT just turned positive on October 22, 2026. Looking at past instances where RDNT's MACD turned positive, the stock continued to rise in 45 of 54 cases over the following month. The odds of a continued upward trend are 83%.
RDNT moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for RDNT crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 80%.
Following a +9.79% 3-day Advance, the price is estimated to grow further. Considering data from situations where RDNT advanced for three days, in 230 of 311 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
The 10-day RSI Indicator for RDNT moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In 29 of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at 71%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 45 of 59 cases where RDNT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 76%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RDNT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.
RDNT broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.457) is normal, around the industry mean (67.298). RDNT's P/E Ratio (-292.308) is considerably lower than the industry average of (4.239). Projected Growth (PEG Ratio) (0.260) is also within normal values, averaging (3.473). Dividend Yield (0.000) settles around the average of (0.002) among similar stocks. P/S Ratio (2.567) is also within normal values, averaging (9.775).
The Tickeron Profit vs. Risk Rating rating for this company is 37 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. RDNT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 77 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Moving Average Convergence Divergence (MACD) for TMDX turned positive on November 04, 2026. Looking at past instances where TMDX's MACD turned positive, the stock continued to rise in 43 of 49 cases over the following month. The odds of a continued upward trend are 88%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on TMDX as a result. In 76 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.
TMDX moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +35.97% 3-day Advance, the price is estimated to grow further. Considering data from situations where TMDX advanced for three days, in 254 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TMDX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
TMDX broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for TMDX entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 28 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. TMDX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 65 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.906) is normal, around the industry mean (4.142). P/E Ratio (19.829) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.709) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (5.033) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 92 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
RDNT | TMDX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 18 | 31 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 1 Undervalued | 70 Overvalued | |
PROFIT vs RISK RATING 1..100 | 37 | 65 | |
SMR RATING 1..100 | 91 | 28 | |
PRICE GROWTH RATING 1..100 | 42 | 41 | |
P/E GROWTH RATING 1..100 | 77 | 92 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
RDNT's Valuation (1) in the Medical Or Nursing Services industry is significantly better than the same rating for TMDX (70) in the Medical Specialties industry. This means that RDNT’s stock grew significantly faster than TMDX’s over the last 12 months.
RDNT's Profit vs Risk Rating (37) in the Medical Or Nursing Services industry is in the same range as TMDX (65) in the Medical Specialties industry. This means that RDNT’s stock grew similarly to TMDX’s over the last 12 months.
TMDX's SMR Rating (28) in the Medical Specialties industry is somewhat better than the same rating for RDNT (91) in the Medical Or Nursing Services industry. This means that TMDX’s stock grew somewhat faster than RDNT’s over the last 12 months.
TMDX's Price Growth Rating (41) in the Medical Specialties industry is in the same range as RDNT (42) in the Medical Or Nursing Services industry. This means that TMDX’s stock grew similarly to RDNT’s over the last 12 months.
RDNT's P/E Growth Rating (77) in the Medical Or Nursing Services industry is in the same range as TMDX (92) in the Medical Specialties industry. This means that RDNT’s stock grew similarly to TMDX’s over the last 12 months.
| RDNT | TMDX | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 71% | 1 day ago 79% |
| Stochastic ODDS (%) | 1 day ago 76% | 1 day ago 80% |
| Momentum ODDS (%) | 1 day ago 74% | 1 day ago 85% |
| MACD ODDS (%) | 1 day ago 83% | 1 day ago 88% |
| TrendWeek ODDS (%) | 1 day ago 72% | 1 day ago 85% |
| TrendMonth ODDS (%) | 1 day ago 80% | 1 day ago 85% |
| Advances ODDS (%) | 8 days ago 74% | 3 days ago 84% |
| Declines ODDS (%) | 6 days ago 73% | 15 days ago 80% |
| BollingerBands ODDS (%) | 1 day ago 74% | 1 day ago 85% |
| Aroon ODDS (%) | 1 day ago 86% | 1 day ago 85% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
RDNT’s FA Score shows that 1 FA rating(s) are green while TMDX’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
RDNT’s TA Score shows that 6 TA indicator(s) are bullish while TMDX’s TA Score has 4 bullish TA indicator(s).
RDNT (@Medical Specialties) experienced а -2.72% price change this week, while TMDX (@Medical/Nursing Services) price change was +26.47% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -4.83%. For the same industry, the average monthly price growth was -5.05%, and the average quarterly price growth was +38.36%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.76%. For the same industry, the average monthly price growth was -4.63%, and the average quarterly price growth was -1.72%.
RDNT is expected to report earnings on Mar 02, 2027.
TMDX is expected to report earnings on Mar 02, 2027.
Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Medical/Nursing Services (-2.76% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor indicates that over the last year, RDNT has been loosely correlated with ITGR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if RDNT jumps, then ITGR could also see price increases.
| Ticker / NAME | Correlation To RDNT | 1D Price Change % | ||
|---|---|---|---|---|
| RDNT | 100% | +0.18% | ||
| ITGR - RDNT | 49% Loosely correlated | +0.05% | ||
| GKOS - RDNT | 48% Loosely correlated | +4.64% | ||
| NNOX - RDNT | 46% Loosely correlated | -2.52% | ||
| ICUI - RDNT | 43% Loosely correlated | -2.11% | ||
| CERS - RDNT | 42% Loosely correlated | +8.72% | ||
More | ||||
A.I.dvisor indicates that over the last year, TMDX has been loosely correlated with ATEC. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if TMDX jumps, then ATEC could also see price increases.
| Ticker / NAME | Correlation To TMDX | 1D Price Change % | ||
|---|---|---|---|---|
| TMDX | 100% | +1.17% | ||
| ATEC - TMDX | 37% Loosely correlated | +5.00% | ||
| RDNT - TMDX | 35% Loosely correlated | +0.18% | ||
| SMTI - TMDX | 34% Loosely correlated | -0.16% | ||
| ALGN - TMDX | 33% Loosely correlated | -1.25% | ||
| PODD - TMDX | 32% Poorly correlated | +1.33% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| LABU | 241.75 | 5.43 | +2.30% |
| Direxion Daily S&P Biotech Bull 3X ETF (LABU) | |||
| AIYY | 7.29 | 0.14 | +1.96% |
| YieldMax AI Option Income Strategy ETF (AIYY) | |||
| UFEB | 39.75 | 0.26 | +0.66% |
| Innovator U.S. Equity Ultra Buffer ETF - February (UFEB) | |||
| QLTY | 44.47 | 0.21 | +0.47% |
| GMO US Quality ETF (QLTY) | |||
| SIMS | 45.22 | -0.48 | -1.06% |
| State Street SPDR S&P Kensho Intelligent Structures ETF (SIMS) | |||